IOL CHEMICALS & PHARM. | OMKAR PHARMACHEM | IOL CHEMICALS & PHARM./ OMKAR PHARMACHEM |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 115.1 | 10.7% | View Chart |
P/BV | x | 1.4 | 2.5 | 56.1% | View Chart |
Dividend Yield | % | 1.1 | 0.0 | - |
IOL CHEMICALS & PHARM. OMKAR PHARMACHEM |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
OMKAR PHARMACHEM Mar-23 |
IOL CHEMICALS & PHARM./ OMKAR PHARMACHEM |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 25 | 2,146.8% | |
Low | Rs | 272 | 19 | 1,406.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 0.5 | 70,492.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.2 | 12,065.2% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.2 | 15,828.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 9.0 | 2,862.3% | |
Shares outstanding (eoy) | m | 58.71 | 10.08 | 582.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 41.4 | 2.6% | |
Avg P/E ratio | x | 17.1 | 113.1 | 15.1% | |
P/CF ratio (eoy) | x | 12.8 | 111.5 | 11.5% | |
Price / Book Value ratio | x | 1.6 | 2.5 | 63.7% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 224 | 10,617.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1 | 121,014.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5 | 410,575.9% | |
Other income | Rs m | 256 | 0 | 853,666.7% | |
Total revenues | Rs m | 22,427 | 5 | 413,023.9% | |
Gross profit | Rs m | 2,257 | 3 | 72,562.7% | |
Depreciation | Rs m | 462 | 0 | 1,538,666.7% | |
Interest | Rs m | 165 | 0 | 35,042.6% | |
Profit before tax | Rs m | 1,887 | 3 | 71,188.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1 | 73,895.5% | |
Profit after tax | Rs m | 1,391 | 2 | 70,272.7% | |
Gross profit margin | % | 10.2 | 57.6 | 17.7% | |
Effective tax rate | % | 26.2 | 25.2 | 104.3% | |
Net profit margin | % | 6.3 | 36.6 | 17.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3 | 368,950.4% | |
Current liabilities | Rs m | 5,025 | 7 | 73,253.6% | |
Net working cap to sales | % | 20.9 | -78.5 | -26.7% | |
Current ratio | x | 1.9 | 0.4 | 503.7% | |
Inventory Days | Days | 43 | 6,286 | 0.7% | |
Debtors Days | Days | 8 | 876 | 0.9% | |
Net fixed assets | Rs m | 11,017 | 93 | 11,841.6% | |
Share capital | Rs m | 587 | 101 | 582.2% | |
"Free" reserves | Rs m | 14,490 | -10 | -139,327.9% | |
Net worth | Rs m | 15,077 | 90 | 16,670.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 96 | 21,622.3% | |
Interest coverage | x | 12.5 | 6.6 | 188.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.1 | 1,898.9% | |
Return on assets | % | 7.5 | 2.6 | 294.2% | |
Return on equity | % | 9.2 | 2.2 | 422.0% | |
Return on capital | % | 13.6 | 3.4 | 395.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 3 | 44,300.7% | |
From Investments | Rs m | -1,200 | NA | - | |
From Financial Activity | Rs m | -41 | -4 | 1,157.7% | |
Net Cashflow | Rs m | -18 | -1 | 2,329.1% |
Indian Promoters | % | 48.2 | 0.0 | 160,633.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.5 | 0.0 | - | |
FIIs | % | 2.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 100.0 | 51.8% | |
Shareholders | 134,235 | 3,600 | 3,728.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | OMKAR PHARMACHEM | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 0.00% | 1.18% |
1-Month | -9.26% | 3.21% | -0.75% |
1-Year | 29.97% | -10.08% | 61.82% |
3-Year CAGR | -13.41% | 4.50% | 18.16% |
5-Year CAGR | 13.41% | 10.90% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the OMKAR PHARMACHEM share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of OMKAR PHARMACHEM the stake stands at 0.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of OMKAR PHARMACHEM.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
OMKAR PHARMACHEM paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of OMKAR PHARMACHEM.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.